The small GTPase Rac and the second messenger cGMP (guanosine 3 0 ,5 0 -cyclic monophosphate) are critical regulators of diverse cell functions. When activated by extracellular signals via membrane signaling receptors, Rac executes its functions through engaging downstream effectors such as p21-activated kinase (PAK), a serine/threonine protein kinase. However, the molecular mechanism by which membrane signaling receptors regulate cGMP levels is not known. Here we have uncovered a signaling pathway linking Rac to the increase of cellular cGMP. We show that Rac uses PAK to directly activate transmembrane guanylyl cyclases (GCs), leading to increased cellular cGMP levels. This Rac/PAK/GC/cGMP pathway is involved in platelet-derived growth factor-induced fibroblast cell migration and lamellipodium formation. Our findings connect two important regulators of cellular physiological functions and provide a general mechanism for diverse receptors to modulate physiological responses through elevating cellular cGMP levels.
INTRODUCTION
The small GTPase Rac plays critical roles in a wide variety of cell functions, including cell-cycle control, regulation of gene expression, activation of NADPH oxidase of phagocytic cells, actin cytoskeletal reorganization, axonal guidance, and cell migration (Jaffe and Hall, 2005) . Rac can be activated by extracellular signals through various types of membrane receptors, including receptor tyrosine kinases such as the PDGF (platelet-derived growth factor) receptor. Rac executes its biological functions through activating downstream effectors. One of the best-characterized downstream effectors of Rac is PAK (p21-activated kinase). PAKs are a highly conserved family of serine/ threonine protein kinases (Bokoch, 2003) . Nearly all eukaryotes contain one or more PAK genes (Hofmann et al., 2004) . PAK family members regulate cellular proliferation, differentiation, transformation, and survival. They also play important roles in cytoskeleton rearrangement during cell migration. Expression of constitutively active PAK stimulates ruffle formation and inhibits stress fibers (Manser et al., 1997; Sells et al., 1997) . Increases in PAK expression and activity have been correlated with progression of colorectal carcinomas to metastasis (Carter et al., 2004) and enhanced motility and invasiveness of human breast cancer cells (Vadlamudi et al., 2000) . In mammals, PAKs can be grouped into two subfamilies: group A (PAK1, 2, and 3) can be activated by small GTPases such as Rac-GTP or Cdc42-GTP binding (Bokoch, 2003) . Group B (PAK4, 5, and 6) can interact with Cdc42-GTP but are not activated by this binding. From the crystal structure of PAK1 (Lei et al., 2000) , it appears that the inactive state is maintained by the Nterminal autoregulatory region (residues 83-149) binding to and inhibiting the C-terminal catalytic kinase domain. This autoregulatory region inhibits PAK1 even when supplied as an independent fragment. Binding of GTP bound Rac (or active Cdc42) releases this inhibition. PAK1 then autophosphorylates Thr423 in its activation loop to stabilize the active state (Lei et al., 2000) . In addition, PAK1, 2, and 3 can be activated by Rac/Cdc42-independent mechanisms such as by caspase-mediated cleavage, by membrane recruitment via adaptor proteins, and by sphingolipids (Bokoch, 2003) .
Like cAMP and Ca
2+
, cGMP is a ubiquitous second messenger mediating cellular responses to various exogenous and endogenous signaling molecules. cGMP controls diverse physiological functions such as relaxation of vascular smooth muscles, phototransduction, epithelial electrolyte transport, bone growth, leukocyte migration, axonal guidance, sperm motility, platelet spreading, and vascular permeability (Lucas et al., 2000) . cGMP regulates physiological processes by activating protein kinases, gating specific ion channels and modulating cellular cyclic nucleotide concentrations through phosphodiesterases (Lucas et al., 2000) . The conversion of GTP to cGMP is catalyzed by guanylyl cyclases (GCs). There are two types of GCs in mammals that are expressed in nearly all cell types: the soluble and the membrane bound GCs (Lucas et al., 2000) . The soluble GCs are generally activated when nitric oxide (NO) binds to the attached prosthetic heme group. Seven membrane bound GCs (also named transmembrane or particulated GCs) have been identified in the human genome (Lucas et al., 2000) . GC-A and GC-B are natriuretic peptide receptors. GC-C can be activated by bacterial heat-stable enterotoxins, guanylin, and uroguanylin. The extracellular ligands for GC-D, GC-E, GC-F, and GC-G are not known. The activity of transmembrane GCs can also be modulated by other receptor signals through intracellular signaling pathways. GC-E and GC-F, found in the retina, can be modulated by a group of retinal-specific cellular proteins named GCAPs (guanylyl cyclase activating proteins) in a calcium-dependent manner (Palczewski et al., 1994) . Moreover, in genetic studies of olfaction in C. elegans, mutants defective in olfaction sensory response have been obtained including daf-11 and odr-1, two transmembrane GCs (Birnby et al., 2000; L'Etoile and Bargmann, 2000) . Reintroduction of the intracellular domain of odr-1 rescued the defective phenotype (L'Etoile and Bargmann, 2000) . Transmembrane GCs function in regulating cell migration and actin cytoskeletal reorganization. The sea urchin sperm membrane bound GC is critical for sperm chemotaxis to the eggs (Bentley et al., 1986) . In addition, Dictyostelium mutants lacking GCs are defective in cell chemotaxis (Bosgraaf et al., 2002) . Furthermore, the Drosophila transmembrane GC Gyc76C has been genetically demonstrated to be essential for axonal guidance (Ayoob et al., 2004) .
Although various types of membrane signaling receptors such as growth-factor receptor tyrosine kinases can increase cellular cGMP levels (Coffey et al., 1988; Scheving et al., 1985) , the molecular mechanism by which these receptors increase cGMP is not known. Here we have discovered a new signaling pathway linking the small GTPase Rac to the increase of cellular cGMP. Our data show that transmembrane GCs can be directly stimulated by intracellular PAK kinases. Previous studies have shown that second messengers such as cGMP and Rho-family small GTPases such as Rac regulate cell migration and actin cytoskeletal reorganization. However, the link between cGMP and Rac has, until now, been missing. Our finding bridges these two important regulators of cellular physiological functions.
RESULTS

Rac Increases Cellular cGMP Levels
In our search for signal transducing molecules that could increase the activity of GCs, we found that Rac1 could increase the GC activity in cells ( Figure 1A ). Untransfected CHO cells have low levels of cellular cGMP that are below the detection limit of our method. Therefore, to reliably measure changes of cellular cGMP, we established CHO cell lines that stably express GC-E (CHO-GC-E cells) (here we use GC-E as an example) ( Figure S1A ). Transient expression of a constitutively activated mutant of Rac1 (Rac1G12V) in these CHO-GC-E cells led to an increase ($3-fold) of cellular cGMP levels ( Figure 1A ). This stimulatory effect is specific to Rac1 since the other two members of the Rho-family small GTPases, RhoA and Cdc42, did not increase the cellular cGMP levels when their constitutively activated mutant forms (RhoA(G14V) and Cdc42(G12V)) were transiently expressed in CHO-GC-E cells ( Figure 1A ). The lack of stimulation by RhoA and Cdc42 was not due to poor expression of these proteins in CHO cells ( Figure 1A , bottom western blots). Furthermore, expression of RhoA(G14V) and Cdc42(G12V) in fibroblast cells led to the formation of actin stress fibers and filopodia, respectively ( Figure S1B ), indicating that these expressed proteins were functional.
To examine whether Rac1 regulation of GC-E is extensive to other GCs, we tested the effect of Rac1 on the activity of GC-A, GC-D, GC-F, and the a 1 b 1 soluble GC. Rac1(G12V) was transiently expressed in cells stably expressing GC-A, GC-D, GC-F, or soluble GC. As shown in Figure 1B , Rac1(G12V) increased the activity of GC-A, GC-D, and GC-F. Rac1 had no effect on the activity of soluble GC even though the cells expressing soluble GC responded to the soluble GC activator sodium nitroprusside ( Figure 1B ). Furthermore, neither RhoA(G14V) nor Cdc42(G12V) had any effect on GC-D activity ( Figure 1B ). These data indicate that Rac1 regulation of transmembrane GCs is a general phenomenon.
To verify that membrane signaling receptors could use this Rac-mediated pathway to modulate cellular cGMP levels, we tested PDGFR as a representative of the growth factor receptor tyrosine kinases. In serum-starved CHO-GC-D cells, PDGF treatment led to higher cellular cGMP levels ( Figure 1C) ; this increase is comparable to that induced by Rac1(G12V) in CHO-GC-D cells ( Figure 1B) . Furthermore, expression of a dominant-negative Rac1 mutant (Rac1(T17N)) blocked PDGF-induced increase of cellular cGMP in CHO-GC-D cells ( Figure 1C and Figure S1C ). In addition, cellular cGMP accumulation was observed beginning at 1 min after PDGF treatment ( Figure 1D ), similar to Rac activation by PDGF (Itoh et al., 2002) . Moreover, in Rac1-deficient mouse embryonic fibroblast (MEF) cells, PDGF-induced increase of cellular cGMP was blocked ( Figure 1E ). Re-expression of Rac1 in these Rac1-deficient cells restored the cGMP response ( Figure 1E ). These data demonstrate that Rac relays the PDGF signal to increase GC activity.
PAK Mediates Rac and PDGF Effect on Cellular cGMP Levels
To understand the molecular mechanism by which Rac1 increases the activity of GCs, we studied the participation of several downstream targets of Rac1 in this regulatory process. We found that PAK is required for this Rac1 function (Figure 2 ). Transient expression of the PAK1 autoinhibitory domain PAK1-(83-149), which inhibits PAK function (Frost et al., 1998) , blocked the stimulation of GC-E by Rac1(G12V) (Figure 2A and Figure S1D ). On the other hand, expression of PAK1-(83-149)L107F, which lacks the inhibitory effect on PAK1, did not block Rac1(G12V)-induced cellular cGMP accumulation (Figure 2A ). Furthermore, consistent with a positive role for PAK in this pathway, we observed that expression of a constitutively active mutant of PAK1 (PAK1-(165-544)) in CHO-GC-E cells increased the cellular cGMP levels ( Figure 2B ). Moreover, the participation of PAK in this modulatory process was verified in the case of PDGF treatment in CHO-GC-D cells ( Figure 2C ). Expression of the inhibitory PAK1 mutant PAK1-(83-149) was shown to block the stimulation of GC-D activity by PDGF, while the noninhibitory mutant PAK1-(83-149)L107F did not ( Figure 2C ). These findings demonstrate that active PAK can substitute for active Rac1 in stimulating GC and that PAK is needed to relay the Rac1 and PDGF signals to GC.
Direct Stimulation of GC-E by Activated PAK
To learn how PAK regulates the activity of GC-E, we examined the possibility that GC-E activity is stimulated directly by PAK. We purified recombinant PAK1 and Rac1. Cellular cGMP levels were measured. Error bars show mean ± SD, **, P < 0.001; *, P < 0.005; ++, P < 0.01; +, P < 0.05 (Student's t test).
PAK2, the intracellular domain of GC-E (GC-E-intra) and Rac1 from either Sf9 cells or E. coli ( Figure 3A ). Purified PAK2 (in the presence of Mg 2+ -ATP) by itself increased the activity of purified GC-E-intra by $2-fold ( Figure 3B ). Addition of Rac1-GTPgS to activate PAK2 led to more than an 8-fold increase of GC-E-intra activity ( Figure 3B ). The stimulatory effect was due to PAK2, since omission of PAK2 or boiled PAK2 sample had no effect on the activity of GC-E-intra even in the presence of Rac1-GTPgS ( Figure 3B ). Furthermore, similar results were obtained with purified PAK1 ( Figure 3B ). Moreover, the activation of GC-E by PAK2 (in the presence of Rac1-GTPgS) was dose dependent with an EC 50 value of $42 nM ( Figure 3C ). Therefore, purified PAK directly activates purified GC-E.
Phosphorylation-Independent Activation of GC by Activated PAK To further study the biochemical mechanism by which PAK activates GC-E, we investigated whether PAK stimulates GC through protein phosphorylation. Using in vitro phosphorylation assays, we found that GC-E-intra was not phosphorylated by PAK2 (with or without Rac1-GTPgS) ( Figure 4A ). The purified PAK2 was catalytically competent since it is capable of autophosphorylation, which was enhanced by Rac1-GTPgS ( Figure 4A ). To rule out the possibility that purified GC-E-intra from E. coli was already phosphorylated, we pretreated purified GC-E-intra with calf intestinal alkaline phosphatase. After removal of the phosphatase by chromatography, a phosphorylation assay was performed, and no phosphorylation of GC-E-intra by PAK2 was observed ( Figure 4B ). To demonstrate that GC-E-intra was phosphorylatable by a protein kinase, we showed that purified GC-E-intra could be phosphorylated by protein kinase A ( Figure S2A ). These data suggest that PAK does not work through direct phosphorylation of GC-E.
We noticed that a PAK1 kinase-dead mutant (PAK1-(165-544)(K298A)) could not stimulate GC-E or GC-D in cells ( Figure 4C ). Furthermore, purified PAK1(K298A) or PAK2(K278A) proteins did not activate purified GC-E-intra with or without Rac1-GTPgS ( Figure 3B ). These data suggest that the kinase activity of PAK is needed for its stimulatory effect on GC. Since PAK does not directly phosphorylate GC, we examined the autophosphorylation of PAK. PAK1 can autophosphorylate itself on several serine and threonine residues including Thr423 (Thr402 in PAK2) at the activation loop of the catalytic domain. Phosphorylation of Thr423 is critical for the conformational change of the activation loop, assembly of the active configuration of the catalytic domain, and activation of PAK1 (Lei et al., 2000) . Therefore, we analyzed the phosphorylation state of purified wild-type PAK2 and PAK1 as well as the kinase-dead PAK1(K298A) or PAK2(K278A) proteins. Western blots with antiphosphoThr423-PAK1/phospho-Thr402-PAK2 antibody showed that the wild-type PAK1 and PAK2 proteins were phosphorylated while PAK1(K298A) and PAK2(K278A) proteins were not ( Figure 4D ). To investigate whether the phosphorylation of PAK is essential for its ability to activate GC, we treated the purified wild-type PAK2 protein with alkaline phosphatase. After removing the phosphatase through chromatography, we found that the dephosphorylated PAK2 could no longer activate GC-E-intra ( Figure 4E ). The dephosphorylated PAK2 could still be activated by Rac1-GTPgS in the presence of ATP leading to Thr402 rephosphorylation; this rephosphorylated PAK2 regained its ability to stimulate GC-E-intra ( Figure 4E ). In addition, we examined the effect of purified PAK2 on the activity of purified GC-D-intra. As shown in Figure 4F , PAK2 (in the presence of Rac1-GTPgS) increased the activity of GC-D-intra. Although Cdc42 did not activate GC in cells, purified PAK2 activated by purified Cdc42-GTPgS increased GC-D-intra activity in vitro, as would be expected ( Figure 4F ). It is not clear why Cdc42 does not activate GCs via PAK in cells. One possible explanation might be that the subcellular localization and/or duration of PAK activated by Rac and by Cdc42 are different. Furthermore, we mutated Thr423 of PAK1 to Glu to mimic the autophosphorylation after activation by Rac. As shown The activity of purified GST-GC-E-intra was assayed in vitro in the presence or absence of purified GST-PAK1, GST-PAK2, GST-PAK1(K298A), GST-PAK2(K278A), and/or Rac1-GTPgS. Data are shown as mean ± SD of three experiments. **, P < 0.001; *, P < 0.005; ++, P < 0.01 (Student's t test). (C) Dose-response curve of the activation of purified GST-GC-E-intra by purified GST-PAK2 in the presence of Rac1-GTPgS. in Figure 4F , purified PAK1(K298A/T423E) significantly increased the activity of GC-D-intra in the absence of Rac1-GTPgS. Moreover, we used immunoprecipitated myc-tagged PAK1 to phosphorylate GST-PAK1(K298A). This phosphorylated PAK1(K298A) increased the activity of GC-D-intra ( Figure 4F ). Therefore, although PAK does not phosphorylate GC, its own phosphorylation is required for its ability to activate GC.
The Kinase Domain of PAK1 Directly Interacts with the Cyclase Domain of GC-E Since GC-E-intra is not a substrate of PAK, we then used five different approaches to investigate the interaction of PAK and GC-E-intra. First, we expressed GFP-tagged GC-E-intra and myc-tagged full-length PAK1 in HEK293 cells ( Figure 5A ). While an anti-GFP antibody coimmunoprecipitated myc-PAK1 in GFP-GC-E-intra and myc-PAK1 cotransfected cells, this antibody did not coimmunoprecipitate myc-PAK1 in control cells cotransfected with GFP-GC-E-intra and myc vector, or with GFP and myc-PAK1 ( Figure 5A ). Second, we examined the interaction of PAK and GC-E-intra in Sf9 cells ( Figure 5B ). We generated recombinant baculoviruses harboring His 6 -tagged GC-E-intra or GST-tagged full-length PAK2. These recombinant baculoviruses were then used to coinfect the Sf9 cells. Glutathione agarose beads were used to pull down GST or GST-PAK2 from the lysate. Western blots with anti-His 6 antibodies revealed that GC-E-intra only coprecipitated with GST-PAK2 but not GST ( Figure 5B ). These results demonstrate that, in both HEK293 and Sf9 cells growing in the presence of serum (thus PAK is active), GC-E-intra forms a complex with PAK. Third, we examined the interaction of endogenous PAK and endogenous GC by using a coimmunoprecipitation assay. Endogenous GC-A from MEF cells was immunoprecipitated by antibodies directed against the C terminus of GC-A ( Figure 5C ). (The specificity of this GC-A antibody was also verified in GC-A transfected HEK293 cells [ Figure S2B ].) Immunoblot analysis with anti-PAK1 antibody showed that PAK1 was found in the immunoprecipitate obtained with anti-GC-A antibody, but not in the immunoprecipitate obtained with control antiserum ( Figure 5C ). Conversely, anti-PAK1 antibody coimmunoprecipitated GC-A in MEF cells ( Figure 5D ). These results show that PAK1 interacts with GC-A in vivo. Fourth, we studied the direct interaction with purified GST-PAK2 and purified His 6 -tagged GC-E-intra as well as purified His 6 -tagged GC-D-intra ( Figures 5E and  S2C ). In the absence of Rac1-GTPgS, we did not observe any direct interaction of PAK2 and GC-E-intra ( Figure 5E , lane 4). On the other hand, when Rac1-GTPgS was included, PAK2 formed a complex with GC-E-intra, with or without ATP ( Figure 5E, lanes 2 and 3) . Hence, a conformation of activated PAK, which can be achieved by the addition of Rac1-GTPgS, is needed for its interaction with GC-E-intra. Fifth, we further characterized the interaction by mapping the interacting domains on both PAK1 and GC-E (Figures 5G and 5H) . We purified GSTfusion proteins of the kinase-homology domain (residues 488-829) of GC-E (GST-GC-E-KHD) and the catalytic cyclase domain (residues 830-1059) of GC-E (GST-GC-E-cat). These GST-fusion proteins and the control GST were used to pull down PAK1 from cell extracts prepared from HEK293 cells transfected with myc-tagged fulllength PAK1, myc-tagged N-terminal regulatory domain of PAK1 (residues 1-270), or myc-tagged PAK1 kinase domain (residues 271-544). We found that the kinase domain of PAK1 directly interacted with the catalytic cyclase domain of GC-E ( Figure 5H ). Therefore, similar to the allosteric activation of transmembrane adenylyl cyclases by G proteins, PAK likely activates GC-E by direct contact with the cyclase domain to induce a conformational change.
GC Is Required for PDGF-Induced Fibroblast Cell Migration
We then studied the physiological significance of the Rac/ cGMP signaling pathway. Since Rac1 and PAK are known to be critical players in cell migration, although the detailed mechanism is not completely defined (Jaffe and Hall, 2005) , we reasoned that Rac1/PAK could use multiple pathways or feedback loops to control cell migration and that Rac1/PAK signaling through GC/cGMP is one of them. Indeed, cGMP, the product of GCs, is known to play a role in cell migration (Estensen et al., 1973) . If that is the case, a decrease of the GC protein levels in cells by RNA interference should impair cell migration. We investigated this possibility in MEF cells. MEF cells mainly express endogenous GC-A (with low levels of GC-B and no GC-E) ( Figure 6A and data not shown). While a mouse GC-A specific siRNA reduced the protein level of GC-A, a control siRNA did not ( Figure 6A ). (With a rhodaminelabeled control siRNA, the transfection efficiency was more than 90%.) Furthermore, the successful reduction of GC-A protein level by RNAi was confirmed by a functional assay: the cGMP production induced by the activation of GC-A with the extracellular ligand atrial natriuretic peptide (ANP) in GC-A siRNA-treated MEF cells was lower than that in control cells ( Figure 6B ). Similarly, PDGF-induced cGMP increase was reduced by GC-A siRNA treatment, and GC-A RNAi did not induce apoptosis or inhibit cell (D) Phosphorylation state of purified PAK proteins. Purified GST-fusion proteins treated with or without calf intestinal alkaline phosphatase (CIP). These protein samples were then separated on SDS-PAGE and western blotted with anti-phospho-Thr423-PAK1/phospho-Thr402-PAK2 antibody. (E) Dephosphorylation of PAK abolished its stimulatory effect on GC. (F) Purified GC-D-intra activation by purified PAK2 in the presence of purified Rac1-GTPgS or Cdc42-GTPgS. Purified PAK1(K298A/T423E) and phosphorylated-PAK1(K298A) could also activate GC-D-intra. Data are shown as mean ± SD of three experiments. **, P < 0.001; *, P < 0.005 (Student's t test).
Figure 5. Direct Interaction of PAK and GC-E
(A) Coimmunoprecipitation of PAK1 and GC-E in HEK293 cells. In bottom panels, anti-myc or anti-GFP antibodies were used to detect the protein expression of transfected genes in whole-cell extracts.
proliferation during the time course of cell migration assays ( Figure 6C and data not shown).
Having successfully reduced the GC-A protein level by RNAi, we used three different approaches to investigate whether the reduction of GC-A protein level would interfere with PDGF-induced cell migration. First, in an in vitro wound-healing assay, while PDGF induced MEF cell migration, the migration of GC-A siRNA-treated cells was reduced ( Figure 6D ). These data demonstrated that GC-A is important for PDGF-induced cell migration. Second, we further confirmed the role of GC in PDGF-induced cell migration by Boyden chamber assay ( Figure 6E ). Similar results were observed when a second different siRNA against GC-A was used ( Figures S3A and S3B) . Furthermore, PDGF-induced MEF cell migration depends on Rac and PAK since expression of dominant-negative Rac1(T17N) and PAK1-(83-149) proteins reduced the cell migration ( Figures 6D and 6E) . Moreover, re-expression of human GC-A in mouse GC-A siRNA-treated MEF cells rescued the PDGF-induced cell migration (there are six nucleotide mismatches between mouse and human GC-As in the sequence against which the siRNA was designed) ( Figure 6F ). In addition, GC-A siRNA inhibited Rac1(G12V)-induced cell migration ( Figure 6G ). Also, expression of dominant-negative PAK1-(83-149) proteins reduced Rac1(G12V)-induced cell migration ( Figure 6G ). Moreover, expression of constitutively active Rac1(G12V) or PAK1-(165-544) increased cellular cGMP levels in MEF cells and in HeLa cells ( Figure 6H ). Additionally, from timelapse recordings, control siRNA-treated MEF cells migrated in response to PDGF ( Figure 6I and Movie S1). On the other hand, most GC-A siRNA-treated cells did not move much ( Figure 6I and Movies S2 and S3). ANP treatment alone or expression of constitutively active PAK alone was not sufficient to induce MEF cell migration, and dominant-negative mutants of Rac1 and PAK1 did not interfere with the direct activation of GC-A by ANP (data not shown). Thus, an increased cGMP level (or a gradient) is required, but by itself not sufficient, for cell migration. Together, these data show that GCs, like Rac and PAK, play a critical role in cell migration.
Role of GC in PDGF-Induced Lamellipodium Formation
To further explore the molecular mechanism by which GC is required for PDGF-induced fibroblast cell migration, we studied the potential role for the Rac/cGMP pathway in lamellipodium formation. Lamellipodia are protruding membrane structures at the leading edge of migrating cells. Rac1 and PAK have been shown to mediate PDGFinduced lamellipodium formation (Ridley et al., 1992; Sells et al., 1999) . We thus investigated whether the Rac/cGMP pathway is involved in lamellipodium formation. As shown in Figures 7A and 7B , migrating MEF cells (treated with a control siRNA) at the edge of a wound in the presence of PDGF displayed lamellipodia ($85% of the cells). Significantly, GC-A siRNA treatment led to the reduction of lamellipodia in the presence of PDGF ($25% of cells with lamellipodia). Furthermore, expression of constitutively active HA-tagged Rac1(G12V) induced the formation of lamellipodia or membrane ruffles (in $100% of infected cells) ( Figures 7C and 7D) . The infected cells were identified by immunostaining with the anti-HA antibody (shown in the inserts of the figures). This effect was inhibited by GC-A RNAi treatment (only $10% of Rac1(G12V)-infected cells displayed lamellipodia) (Figure 7C and 7D) . Moreover, although ANP alone was not sufficient to induce MEF cell migration, it induced transient formation of lamellipodia ( Figure 7E ). These data suggest that GC is involved in PDGF-and Rac1-induced lamellipodium formation.
We also investigated the potential effect of GC on cell polarity. In the presence of PDGF, cells at the wound edge become polarized and extend a long protrusion into the wound. The microtubule organizing center (MTOC) (stained with anti-pericentrin antibodies) and the microtubule cytoskeleton (stained with anti-tubulin antibodies) reorganize to face the wound (Etienne-Manneville and Hall, 2001) ( Figure 7F ). GC-A RNAi did not affect the cell polarity. In both control siRNA-treated cells and GC-A siRNA-treated cells, PDGF induced $60-70% of cells in the front row to exhibit a polarized MTOC ( Figure 7G ). In the absence of PDGF, random orientation of the MTOC facing the wound corresponds to $30% of cells ( Figure 7G ). Therefore, GC-A RNAi did not prevent the formation of protrusions and the polarization of the MTOC.
DISCUSSION
We have uncovered a new cellular signaling pathway that links the small GTPase Rac and the second messenger cGMP ( Figure 7H ). Since Rac and PAK have been linked to various receptor signaling, this new Rac/PAK/GC/ cGMP pathway could provide a general mechanism for various types of signaling receptors to increase the cellular concentrations of cGMP. We have shown here that PAK directly increases the activity of purified GC. Other purified protein kinases including PKC, PKA, Src, Abl, or Csk had no effect on the activity of GC-E or GC-D in vitro (unpublished data), suggesting that the effect on GCs is rather specific to PAK kinases. PAK does not phosphorylate GC. Rather, PAK contacts the cyclase domain of GC, likely causing a conformational change and activation of GC. This allosteric mechanism (direct contact and conformational change) is similar to the proposed mechanisms for the activation of membrane bound GCs by their ligands such as ANP, of soluble GCs by NO, and adenylyl cyclases by heterotrimeric G proteins (Lucas et al., 2000; Tesmer et al., 1997) .
The phosphorylation-independent function of PAK1 has been described before, although the molecular mechanism was not known (Bokoch, 2003; Daniels et al., 1998; Frost et al., 1998; Sells et al., 1997) . For example, PAK1 induces lamellipodium formation and membrane ruffling in fibroblasts and neurite outgrowth in PC12 cells, independent of its catalytic activity (Daniels et al., 1998; Frost et al., 1998) . Furthermore, a recent crystal structure of the dimer of the kinase domain of EGFR could provide a potential structural basis for how the PAK kinase domain allosterically activates GCs (Zhang et al., 2006) . In this asymmetric dimer of the EGFR kinase domain, one kinase domain (using its C-terminal lobe) allosterically activates the second kinase domain (by contacting the N-terminal lobe and changing the conformation of the active site of the second kinase domain into the active state) (Zhang et al., 2006) . This activation does not involve the phosphorylation of one kinase domain by the other kinase domain. The first kinase domain acts as an allosteric activator.
Transmembrane GCs could serve dual roles to increase cellular cGMP levels to different degrees, thus leading to possible different, sometimes opposing, physiological effects. Extracellular ligands such as ANP bind to transmembrane GCs and activate their cyclase activity leading to $100-to 1000-fold increase of cellular cGMP levels. On the other hand, growth-factor receptors and other membrane receptors could use the Rac/cGMP pathway or the GCAP proteins in retinal cells to stimulate the cyclase activity of transmembrane GCs from the interior of the cell leading to $3-to10-fold increase of cellular cGMP levels. As the effect of cGMP on physiological processes is dependent on cGMP concentrations (Elferink and VanUffelen, 1996) , it is conceivable that activation of transmembrane GCs by growth factors and by ligands such as ANP could lead to different responses, depending on the cell type and the spatio-temporal dynamics of cGMP in living cells.
PAKs regulate a variety of physiological processes such as cell migration, morphological changes, gene expression, cell proliferation, and differentiation. Here we have shown that the PAK/GC/cGMP pathway is part of the regulatory mechanism by which PDGF induces fibroblast cell migration. The molecular mechanism of action of cGMP in cell migration is still poorly understood. One of the major targets of cGMP is cGMP-dependent protein kinase (PKG). A major substrate of PKG is VASP (vasodilatorstimulated phosphoprotein). Cells overexpressing VASP have lamellipodia that protrude faster than control cells, but these protrusions are rapidly withdrawn (Krause et al., 2003) . Thus, VASP increases lamellipodium protrusion velocity but has an overall negative effect on wholecell motility (Krause et al., 2003) . PKG phosphorylation of VASP is proposed to relieve this negative effect on cell migration (Krause et al., 2003) . There are other potential targets for cGMP in regulating cell migration. cGMP could regulate Ca 2+ influx, intracellular Ca 2+ concentration, myosin phosphatase activation, and myosin phosphorylation (Sauzeau et al., 2000; Schlossmann et al., 2000; Surks et al., 1999) . Furthermore, cGMP could positively regulate the activity of Rac and PAK, forming a positive feedback loop. 8-Br-cGMP, through PKG, could activate Rac and PAK in HEK293 cells (Hou et al., 2004) . Although PKG did not directly phosphorylate Rac, they colocalize on membrane ruffles (Hou et al., 2004) . This feedback regulation might be one of the many feedback loops that are essential for the repetitive behavior of cell migration.
The new Rac/cGMP pathway might have implications for studies on axonal guidance. The control of actin cytoskeletal reorganization lies at the core of axon guidance. Rho-family GTPases play a key role in transmitting extracellular signals to changes in actin cytoskeletal structure and motility in growth cones. In Drosophila photoreceptor axonal guidance, both Rac and PAK have been genetically demonstrated to play critical roles (Hing et al., 1999; Newsome et al., 2000) . However, the downstream signaling molecules have not yet been defined. On the other hand, in Xenopus spinal neurons and rat sensory neurons, the ratio of cAMP/cGMP is important in axonal guidance, yet the upstream signaling components modulating the cyclic nucleotide levels within neurons are not clear (Nishiyama et al., 2003; Song et al., 1998) . Furthermore, the Drosophila transmembrane GC Gyc76C is essential for motor axon guidance downstream of Semaphorin-1a-Plexin A signaling (Ayoob et al., 2004) . Moreover, mouse genetic studies have shown that cGMP-mediated signaling through PKG is required for spinal cord sensory neuron guidance and connectivity (Schmidt et al., 2002) . Our finding that Rac/ PAK regulates GC/cGMP provides new insights that could potentially unify these seemingly different axonal guidance pathways. Moreover, our discovery of the Rac/PAK/GC/ cGMP pathway opens the way for further studies on the role of cGMP in Rac/PAK signaling and of Rac/PAK in cGMP signaling in various biological processes.
EXPERIMENTAL PROCEDURES
Cell Culture and Coimmunoprecipitation CHO-GC cells were generated by stably transfecting CHO-K1 cells with plasmids encoding GCs. CHO-K1 cells were cultured in F12K nutrient mixture (Kaighn's modification) containing 10% fetal bovine serum (Invitrogen). Transfections of CHO-K1 cells were performed with Transfast (Promega). HEK293 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Transfections of HEK293 cells were performed using either calcium phosphate or Lipofectamine2000 (Invitrogen). MEF cells were routinely cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum.
Generation of Rac1-deficient cells from Rac1 flox/flox mice has been described before (Gu et al., 2003; Guo et al., 2006 Coimmunoprecipitations and western blots were performed as previously described (Ma et al., 2000; Wan et al., 1996) . For the coimmunoprecipitation experiments of PAK1 and GC-A, anti-GC-A antibody was from FabGennix, Inc. International (Shreveprot, LA) (Cat. # PGCA-100). Anti-PAK1 antibody was from Cell Signaling Technology (MA) (Cat. # 2602). The anti-pPAK1(T423)/pPAK2(T402) antibody was from Cell Signaling Technology (MA) (Cat. # 2601S).
Protein Purification
GST-tagged intracellular domain of GC-E (GST-GC-E-intra) was purified from E. coli. His-tagged GC-E-intra protein was purified from HighFive insect cells (Invitrogen). Baculoviruses containing GST-PAK1, GST-PAK2, GST-PAK1(K298A), GST-PAK2(K278A), GST-PAK1-KD(K298A), and GST-PAK1(K298A/T423E) were amplified in Sf9 cells and then used to infect 2 l of High-Five cells. The GST-tagged protein was purified using glutathione beads, followed by a Sephadex G-200 column (Pharmacia). His-tagged Rac1 was purified from E. coli using Ni-NTA beads (Qiagen). Rac1 was activated by incubating with 100 mM of GTPgS in the loading buffer (20 mM Tris, pH 8, 100 mM NaCl, 0.2 mM DTT, 1 mM EDTA) for 10 min at 30 C.
GST Pull-Down Assay GST pull-down assays were done as previously described with purified proteins or with baculovirus-infected Sf9 cell lysates (Lowry et al., 2002; Ma et al., 2000) .
Guanylyl Cyclase Activity Assay
In vivo cGMP concentrations were determined from cell lysates with the Direct cGMP Assay Kit from Assay Designs, Inc. In general, cells were incubated for 18-24 hr after transfection before the medium was changed to serum-free medium. Transfection efficiency of CHO cells was $90% based on transfection with a GFP plasmid. After 24 hr of starvation, cells were incubated with 0.5 mM IBMX for 30 min. Cells were washed once with ice-cold 1X PBS and lysed in 0.5% Triton X-100 containing 0.5 mM IBMX. We empirically determined the dilution factor for each cell lysate so that the experimental readings fall in the middle of the linear standard curve of the Direct cGMP Assay Kit. For the in vitro guanylyl cyclase activity assay, purified proteins were mixed in 50 ml of reaction buffer (50 mM Hepes, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 , 1 mM DTT, 1 mM GTP) and incubated for 20 min at 30 C. GTP was added last to start the reaction (there was no detergent in these reactions). The reaction was terminated by adding HCl to a final concentration of 0.1 M. The mixture was diluted 5-to 10-fold in 0.1 M HCl, and the cGMP content was determined with the Direct cGMP Assay Kit from Assay Designs, Inc.
RNA Interference
RNAi of GC-A was performed in MEF cells with Qiagen's HiPerformance 2-for-Silencing siRNA duplexes. The target sequence for the first siRNA was CCGGACCACTACACCAAGCTA. There are six nucleotide differences between human and mouse GC-A in this region. The target sequence for the second siRNA was AACGCATTGAGTTGACACGAA. siRNA and Oligofectamine were diluted and mixed in OptiMEM I (Invitrogen) to allow the formation of siRNA-liposome complexes. After a 20 min incubation at room temperature, the mixture was overlayed onto MEF cells (50% confluent) cultured in medium without antibiotics. The transfected cells were analyzed 72-96 hr after transfection.
In Vitro Phosphorylation Assay Phosphorylation assay was done as previously described (Wan et al., 1996) .
Wound-Healing Assays and Chamber Assay
In vitro wound-healing assays and Boyden chamber assays were performed as previously described (Shan et al., 2005; Yang and Huang, 2005) .
Fluorescence Microscopy
Fluorescence microscopy was done as previously described (Lowry et al., 2002) .
MTOC Reorientation
MTOC reorientation (cell polarization) was analyzed as previously described (Etienne-Manneville and Hall, 2001) . MTOCs were labeled with anti-pericentrin antibodies. Cells in which the MTOC was within the quadrant facing the wound were scored positive, and for each condition, at least 100 cells were examined.
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